article thumbnail

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.

article thumbnail

Sustainable energy strategies for pharmaceutical manufacturers

European Pharmaceutical Review

Actions can include optimising behind-the-meter assets, procuring renewable energy through power purchase agreements (PPAs), and participating in capacity, ancillary and energy market programmes to optimise energy use and support the electricity grid to manage increasing levels of renewable energy. Resiliency and renewables.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why today’s leading pharma manufacturers are adopting proactive asset management strategies

PharmaVoice

In recent months, high-profile drug shortages have brought pharmaceutical manufacturing operations into the spotlight.

article thumbnail

Elevating pharmaceutical manufacturing processes with real-time insights

European Pharmaceutical Review

The Fourier PAT includes a Fourier 80 compact NMR analyser equipped with a synTQ NMR dadpter that enables the integration with synTQ PAT knowledge management software. This can lead to refined (bio)pharmaceutical manufacturing operations that propel product quality, operational efficiency and overall productivity to new heights.

article thumbnail

Economics and risks of FDA’s Quality management maturity rating programme

European Pharmaceutical Review

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

article thumbnail

Pharma Horizons: Sustainability

European Pharmaceutical Review

Register your details now to download >>> This Pharma Horizons report is brought to you in association with: The post Pharma Horizons: Sustainability appeared first on European Pharmaceutical Review. Interested?

Pharma 59
article thumbnail

DCAT Week 2025: Key Ingredients in Pharmaceutical Manufacturing

PharmaTech

Roquette Pharma Solutions' Christine Mya-San, global account manager, highlights the most significant pharma ingredients at play over the past year and discusses future ingredient innovation.